Prospective randomized controlled clinical and histopathological study of acne vulgaris treated with dual mode of quasi-long pulse and Q-switched 1064-nm Nd:YAG laser assisted with a topically applied carbon suspension

Published:October 28, 2011DOI:


      Acne treatments using laser and light devices have been reported to have varying degrees of efficacy. However, there has been no study of treatment of acne using a dual mode (quasi-long pulse and Q-switched mode) 1064-nm Nd:YAG laser assisted with a topically applied carbon suspension.


      To evaluate the clinical efficacy, safety, and histological changes of new laser treatment method for acne vulgaris.


      Twenty-two patients received 3 sessions of quasi-long pulse and Q-switched Nd:YAG laser treatment assisted with a topically applied carbon suspension at 2-week intervals in a randomized split face manner.


      At the final visit, the inflammatory acne lesions were reduced on the laser-treated side by 58.6% (P < .001), but increased on the untreated side by 5%. The noninflammatory acne lesions were reduced on the laser-treated side by 52.4% (P < .001). Sebum output reduction, inflammatory cell and cytokine reductions, a decrease of the thickness of a perifollicular stratum corneum and a full epithelium, and skin rejuvenation effect were found. The histopathologic examination of the acne lesions showed decreased inflammation and immunostaining intensity for interleukin 8, matrix metalloproteinase-9, toll-like receptor-2, and nuclear factor kappa B, and tumor necrosis factor alpha was reduced significantly. No severe adverse reactions were reported. All patients reported mild transient erythema that disappeared in a few hours.


      The number of subjects studied was small.


      This laser treatment was rapid and effective for treating not only the inflammatory but also the noninflammatory acne lesions when compared with the control side. The histopathologic findings correlated well with the clinical acne grade and treatment response. This novel laser treatment appears to be safe and effective for acne treatment.

      Key words

      Abbreviations used:

      H&E (hematoxylin and eosin), HSP (heat shock protein), IL (interleukin), MMP (matrix metalloproteinase), Nd:YAG (neodymium:yttrium-aluminium-garnet), NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells), PDL (pulsed dye laser), TGF-β (transforming growth factor beta), TLR (toll like receptor), TNF-α (tumor necrosis factor alpha), VAS (visual analogue scale)
      To read this article in full you will need to make a payment
      AAD Member Login
      AAD Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Leyden J.J.
        Therapy for acne vulgaris.
        N Engl J Med. 1997; 336: 1156-1162
        • Goodman G.
        Acne—natural history, facts and myths.
        Aust Fam Physician. 2006; 35: 613-616
        • Na J.I.
        • Suh D.H.
        Red light phototherapy alone is effective for acne vulgaris: randomized, single-blinded clinical trial.
        Dermatol Surg. 2007; 33: 1228-1233
        • Papageorgiou P.
        • Katsambas A.
        • Chu A.
        Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris.
        Br J Dermatol. 2000; 142: 973-978
        • Sigurdsson V.
        • Knulst A.C.
        • van Weelden H.
        Phototherapy of acne vulgaris with visible light.
        Dermatology. 1997; 194: 256-260
        • Orringer J.S.
        • Kang S.
        • Hamilton T.
        • Schumacher W.
        • Cho S.
        • Hammerberg C.
        • et al.
        Treatment of acne vulgaris with a pulsed dye laser: a randomized controlled trial.
        JAMA. 2004; 291: 2834-2839
        • Jung J.Y.
        • Choi Y.S.
        • Yoon M.Y.
        • Min S.U.
        • Suh D.H.
        Comparison of a pulsed dye laser and a combined 585/1,064-nm laser in the treatment of acne vulgaris.
        Dermatol Surg. 2009; 35: 1181-1187
        • Seaton E.D.
        • Charakida A.
        • Mouser P.E.
        • Grace I.
        • Clement R.M.
        • Chu A.C.
        Pulsed-dye laser treatment for inflammatory acne vulgaris: randomised controlled trial.
        Lancet. 2003; 362: 1347-1352
        • Orringer J.S.
        • Kang S.
        • Maier L.
        • Johnson T.M.
        • Sachs D.L.
        • Karimipour D.J.
        • et al.
        A randomized, controlled, split-face clinical trial of 1320-nm Nd:YAG laser therapy in the treatment of acne vulgaris.
        J Am Acad Dermatol. 2007; 56: 432-438
        • Glaich A.S.
        • Friedman P.M.
        • Jih M.H.
        • Goldberg L.H.
        Treatment of inflammatory facial acne vulgaris with combination 595-nm pulsed-dye laser with dynamic-cooling-device and 1,450-nm diode laser.
        Lasers Surg Med. 2006; 38: 177-180
        • Goldberg D.J.
        • Whitworth J.
        Laser skin resurfacing with the Q-switched Nd:YAG laser.
        Dermatol Surg. 1997; 23 (discussion 906-7): 903-906
        • Sumian C.C.
        • Pitre F.B.
        • Gauthier B.E.
        • Bouclier M.
        • Mordon S.R.
        Laser skin resurfacing using a frequency doubled Nd:YAG laser after topical application of an exogenous chromophore.
        Lasers Surg Med. 1999; 25: 43-50
        • O'Brien S.C.
        • Lewis J.B.
        • Cunliffe W.J.
        The Leeds revised acne grading system.
        J Dermatol Treat. 1998; 9: 215-220
        • Trelles M.A.
        • Allones I.
        • Luna R.
        Facial rejuvenation with a nonablative 1320 nm Nd:YAG laser: a preliminary clinical and histologic evaluation.
        Dermatol Surg. 2001; 27: 111-116
        • Friedman P.M.
        • Jih M.H.
        • Skover G.R.
        • Payonk G.S.
        • Kimyai-Asadi A.
        • Geronemus R.G.
        Treatment of atrophic facial acne scars with the 1064-nm Q-switched Nd:YAG laser: six-month follow-up study.
        Arch Dermatol. 2004; 140: 1337-1341
        • Keller R.
        • Belda Junior W.
        • Valente N.Y.
        • Rodrigues C.J.
        Nonablative 1,064-nm Nd:YAG laser for treating atrophic facial acne scars: histologic and clinical analysis.
        Dermatol Surg. 2007; 33: 1470-1476
        • Lee D.H.
        • Choi Y.S.
        • Min S.U.
        • Yoon M.Y.
        • Suh D.H.
        Comparison of a 585-nm pulsed dye laser and a 1064-nm Nd:YAG laser for the treatment of acne scars: a randomized split-face clinical study.
        J Am Acad Dermatol. 2009; 60: 801-807
        • Min S.U.
        • Choi Y.S.
        • Lee D.H.
        • Yoon M.Y.
        • Suh D.H.
        Comparison of a long-pulse Nd:YAG laser and a combined 585/1,064-nm laser for the treatment of acne scars: a randomized split-face clinical study.
        Dermatol Surg. 2009; 35: 1720-1727
        • Alam M.
        • Hsu T.S.
        • Dover J.S.
        • Wrone D.A.
        • Arndt K.A.
        Nonablative laser and light treatments: histology and tissue effects—a review.
        Lasers Surg Med. 2003; 33: 30-39
        • Kang S.
        • Cho S.
        • Chung J.H.
        • Hammerberg C.
        • Fisher G.J.
        • Voorhees J.J.
        Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo.
        Am J Pathol. 2005; 166: 1691-1699
        • Yamamoto Y.
        • Gaynor R.B.
        Role of the NF-kappaB pathway in the pathogenesis of human disease states.
        Curr Mol Med. 2001; 1: 287-296
        • Boone D.L.
        • Lee E.G.
        • Libby S.
        • Gibson P.J.
        • Chien M.
        • Chan F.
        • et al.
        Recent advances in understanding NF-kappaB regulation.
        Inflamm Bowel Dis. 2002; 8: 201-212
        • Angel P.
        • Karin M.
        Specific members of the Jun protein family regulate collagenase expression in response to various extracellular stimuli.
        Matrix Suppl. 1992; 1: 156-164
        • Crowe D.L.
        • Tsang K.J.
        • Shemirani B.
        Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression.
        Neoplasia. 2001; 3: 27-32
        • Birkedal-Hansen H.
        • Moore W.G.
        • Bodden M.K.
        • Windsor L.J.
        • Birkedal-Hansen B.
        • DeCarlo A.
        • et al.
        Matrix metalloproteinases: a review.
        Crit Rev Oral Biol Med. 1993; 4: 197-250
        • Kim J.
        • Ochoa M.T.
        • Krutzik S.R.
        • Takeuchi O.
        • Uematsu S.
        • Legaspi A.J.
        • et al.
        Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses.
        J Immunol. 2002; 169: 1535-1541